Market revenue in 2023 | USD 2,994.4 million |
Market revenue in 2030 | USD 4,325.8 million |
Growth rate | 5.4% (CAGR from 2023 to 2030) |
Largest segment | In house |
Fastest growing segment | Contract Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In House, Contract Outsourcing |
Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.
In house was the largest segment with a revenue share of 58.89% in 2023. Horizon Databook has segmented the U.S. veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. market is anticipated to grow substantially over the forecast period due to the increasing number of animal healthcare centers and practitioners. According to the American Veterinary Medical Association (AVMA) report, in 2022, around 124,069 veterinary practitioners were practicing in the country.
Further, growing concerns about pets have increased pet care expenditure, driving the veterinary medicine demand. This is expected to propel the veterinary API manufacturing market growth.
According to a report by APPA, in 2022, on average, an owner spent approximately USD 31.5 billion on supplies, live animals, and Over-the-Counter (OTC) medications. These aforementioned factors are anticipated to propel the veterinary API manufacturing market growth in the U.S.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. veterinary active pharmaceutical ingredients manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account